International Isotopes Inc INIS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if INIS is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.04
- Day Range
- $0.04–0.04
- 52-Week Range
- $0.02–0.10
- Bid/Ask
- $0.02 / $0.04
- Market Cap
- $21.84 Mil
- Volume/Avg
- 16,895 / 78,631
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.77
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
International Isotopes Inc manufactures a full range of nuclear medicine calibration and reference standards, cobalt teletherapy sources, and other sealed sources. International Isotopes also distributes a varied selection of radioisotopes and radiochemicals for medical and clinical research, and pharmacy compounding. International Isotopes's business consists of four business segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, and Fluorine Products. Geographically, it generates the majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 40
- Website
- https://www.intisoid.com
Valuation
|
Metric
|
INIS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 5.41 |
Price/Sales | 1.77 |
Price/Cash Flow | — |
Price/Earnings
INIS
Financial Strength
|
Metric
|
INIS
|
|---|---|
Quick Ratio | 1.27 |
Current Ratio | 1.76 |
Interest Coverage | −1.86 |
Quick Ratio
INIS
Profitability
|
Metric
|
INIS
|
|---|---|
Return on Assets (Normalized) | −2.49% |
Return on Equity (Normalized) | −9.57% |
Return on Invested Capital (Normalized) | −1.82% |
Return on Assets
INIS
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Whyfnsbdq | Cjrlxv | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Ysjrmgqs | Gsb | $68.9 Bil | |
HLN
| Haleon PLC ADR | Bhkvckth | Dbkdt | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Hptygmzn | Nfzx | $14.7 Bil | |
VTRS
| Viatris Inc | Ybdtcqx | Msyn | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Lhvnbrbyd | Gppr | $11.9 Bil | |
CTLT
| Catalent Inc | Fjktvcvnq | Mjqffvy | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Ylqktmdrm | Trzd | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Lgknrthdr | Kxlw | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ldfsymmxs | Rhvtmy | $3.5 Bil |